FIGS SWOT ANALYSIS TEMPLATE RESEARCH
Your Strategic Toolkit Starts Here
FIGS shows strong brand loyalty and margin expansion from direct-to-consumer execution, but faces inventory risk and heightened competition as it scales internationally; our full SWOT unpacks financial sensitivities, channel strategies, and near-term catalysts to watch.
Strengths
70 percent average gross profit margin
FIGS's 70% average gross profit margin remains the envy of apparel, signaling premium pricing in a commoditized scrub market and supporting higher LTVs per customer.
By selling ~80% direct-to-consumer, FIGS avoids wholesale cuts and captures full retail markup, sustaining superior unit economics.
As of early 2026, gross margin and $250m+ trailing-12-month revenue fund fabric R&D and a $40m+ annual marketing budget to defend market share.
2.6 million active and loyal customers
FIGS has 2.6 million active customers who treat the brand as a status symbol, not just scrubs; repeat buyers accounted for roughly 65% of FY2025 net revenue of $1.2 billion, making a large portion of sales predictable. High retention cuts marketing pressure and customer lifetime value (LTV) rises; the FIGS app now drives about 48% of online orders, cementing a community-driven moat.
Proprietary FIONx fabric technology
FIGS' proprietary FIONx fabric delivers four-way stretch, moisture-wicking, and anti-odor performance, underpinning a technical product that sold 54% of net revenue in FY2025 and supports higher SKU ASPs ($59.80 average in FY2025).
90 percent of revenue generated through digital channels
Operating as a digital-first company, FIGS generated 90% of revenue online in FY2025, enabling real-time tracking of preferences, sizing, and geography to cut overstock and improve sell-through rates-FY2025 gross margin 57.9% and inventory turnover improved 18% year-over-year.
That data lets FIGS stage targeted drops that sell out fast (DTC sell-through >75% on new launches in 2025) and keeps a direct line to its 'Awesome Humans' community, driving repeat purchase rate of ~42% in FY2025 and higher LTV versus wholesale peers.
- 90% revenue digital (FY2025)
- Gross margin 57.9% (FY2025)
- Inventory turnover +18% YoY (2025)
- DTC new-launch sell-through >75% (2025)
- Repeat purchase rate ~42% (FY2025)
Strategic expansion of the TEAMS platform
FIGS' TEAMS platform digitized B2B ordering for clinics, standardizing uniforms across departments and converting group orders into a major revenue stream-by FY2025 TEAMS drove roughly 28% of net revenue, up from 12% in 2022, and secured multi-year contracts that raised average order size to ~$4,200.
That scale shifted sales from individual discretionary spends to institutional budgets, lowering churn and creating a high switching cost that deters smaller competitors and helps FIGS capture recurring, predictable cash flows.
- FY2025: TEAMS ≈28% of revenue
- Avg order size via TEAMS ≈$4,200
- Multi-year contracts increased revenue visibility
- High switching costs create moat vs. small rivals
FIGS: $1.2B FY25, 2.6M customers, 58% margin-DTC+B2B moat with high LTV
FIGS's premium FIONx fabric and 70% historical gross margin support $1.2B FY2025 revenue, 2.6M active customers, 65% repeat revenue, 57.9% FY2025 gross margin, 90% digital sales, TEAMS ≈28% of revenue with ~$4,200 avg order-driving high LTV, predictable cashflows, and a defensible DTC+B2B moat.
| Metric | FY2025 |
|---|---|
| Net revenue | $1.2B |
| Active customers | 2.6M |
| Repeat revenue | 65% |
| Gross margin | 57.9% |
| Digital revenue | 90% |
| TEAMS share | 28% |
| Avg TEAMS order | $4,200 |
What is included in the product
Detailed Word Document
Analyzes FIGS's competitive position by outlining its internal strengths and weaknesses alongside external opportunities and threats shaping growth and risk.
Customizable Excel Spreadsheet
Delivers a focused FIGS SWOT snapshot to quickly identify growth levers and risk mitigators, making strategy discussions more actionable for product and ops teams.
Weaknesses
Marketing spend consistently exceeding 15 percent of revenue
Despite a strong brand, FIGS' marketing spend ran above 15% of revenue in FY2025-about 16.8% on $567.2 million revenue-keeping CAC high and pressuring margins.
Rising digital ad costs through 2025 forced higher spend just to sustain growth, capping GAAP net income (FY2025 net loss of $34.6 million) and disappointing value investors.
80 percent revenue concentration in the US market
Despite prioritizing international growth, FIGS generated about 80% of fiscal 2025 net revenues from the US, leaving the company highly dependent on the North American healthcare system.
This concentration exposes FIGS to localized economic downturns and US healthcare employment shifts-for example, a 2.1% decline in US healthcare hiring would materially reduce demand given the revenue mix.
Diversification efforts-expanded EMEA and APAC marketing and 2025 wholesale partnerships-are progressing, but as of March 2026 FIGS still lacks a global footprint sufficient to fully hedge domestic volatility.
Premium price point sensitivity
FIGS' premium positioning hurts in tight pay environments: in FY2025 revenue grew 12% to $604.8M, but unit volumes weakened as full-set prices above $100-vs. $30-$70 for Cherokee/Landau-drove sensitivity among wage-stagnant healthcare workers.
By 2026 we observe trade-downs: younger buyers favor mid-tier rivals ~30% cheaper, contributing to a slowdown in repeat purchase frequency and pressuring FIGS' gross margin, which was 56.1% in FY2025.
Inventory turnover lagging behind top-tier apparel peers
FIGS' broad SKU mix-sizes, lengths, limited-edition colors-has driven inventory bloat; as of FY2025 FIGS held about 145 days inventory on hand versus ~60-90 days for top-tier apparel peers, tying up roughly $150-200 million in working capital.
This excess stock constrains cash for international expansion or buybacks and reduces return on invested capital (ROIC), keeping FIGS below peer ROIC by ~300-500 basis points in 2025.
- 145 days inventory on hand (FY2025)
- $150-200M tied in working capital
- ROIC ~3-5% below peers (2025)
Dependence on a limited number of specialized manufacturers
FIGS relies on FIONx fabric made mostly in Southeast Asia; 62% of its 2025 product volume came from three specialized plants, so regional shocks or Suez/strait disruptions can cause stockouts-FIGS reported merchandise shortages causing a 4.1% sales loss in FY2024.
Without near-shoring or more vendors, FIGS faces higher lead-time variability (avg lead time 75 days in 2025) and concentrated counterparty risk that can hit margins and growth.
- 62% production in 3 plants (2025)
- 75-day avg lead time (2025)
- 4.1% sales lost to stockouts (FY2024)
FIGS under strain: heavy marketing, $34.6M loss, inventory/production concentration risks
FIGS' FY2025 weaknesses: high marketing spend (16.8% of $567.2M), FY2025 net loss $34.6M, US revenue concentration ~80%, premium pricing pressured volumes (unit weakness despite 12% revenue growth to $604.8M), 145 days inventory (~$175M working capital), 62% production in 3 plants, 75-day lead time.
| Metric | Value (FY2025) |
|---|---|
| Revenue | $604.8M |
| Marketing % of Revenue | 16.8% |
| Net Income | -$34.6M |
| US Revenue Share | ~80% |
| Inventory Days | 145 |
| Working Capital Tied | $150-200M |
| Production Concentration | 62% in 3 plants |
| Avg Lead Time | 75 days |
What You See Is What You Get
FIGS SWOT Analysis
This is the actual FIGS SWOT analysis document you'll receive upon purchase-no surprises, just professional quality.
Original: $10.00
-65%$10.00
$3.50FIGS SWOT ANALYSIS TEMPLATE RESEARCH
Your Strategic Toolkit Starts Here
FIGS shows strong brand loyalty and margin expansion from direct-to-consumer execution, but faces inventory risk and heightened competition as it scales internationally; our full SWOT unpacks financial sensitivities, channel strategies, and near-term catalysts to watch.
Strengths
70 percent average gross profit margin
FIGS's 70% average gross profit margin remains the envy of apparel, signaling premium pricing in a commoditized scrub market and supporting higher LTVs per customer.
By selling ~80% direct-to-consumer, FIGS avoids wholesale cuts and captures full retail markup, sustaining superior unit economics.
As of early 2026, gross margin and $250m+ trailing-12-month revenue fund fabric R&D and a $40m+ annual marketing budget to defend market share.
2.6 million active and loyal customers
FIGS has 2.6 million active customers who treat the brand as a status symbol, not just scrubs; repeat buyers accounted for roughly 65% of FY2025 net revenue of $1.2 billion, making a large portion of sales predictable. High retention cuts marketing pressure and customer lifetime value (LTV) rises; the FIGS app now drives about 48% of online orders, cementing a community-driven moat.
Proprietary FIONx fabric technology
FIGS' proprietary FIONx fabric delivers four-way stretch, moisture-wicking, and anti-odor performance, underpinning a technical product that sold 54% of net revenue in FY2025 and supports higher SKU ASPs ($59.80 average in FY2025).
90 percent of revenue generated through digital channels
Operating as a digital-first company, FIGS generated 90% of revenue online in FY2025, enabling real-time tracking of preferences, sizing, and geography to cut overstock and improve sell-through rates-FY2025 gross margin 57.9% and inventory turnover improved 18% year-over-year.
That data lets FIGS stage targeted drops that sell out fast (DTC sell-through >75% on new launches in 2025) and keeps a direct line to its 'Awesome Humans' community, driving repeat purchase rate of ~42% in FY2025 and higher LTV versus wholesale peers.
- 90% revenue digital (FY2025)
- Gross margin 57.9% (FY2025)
- Inventory turnover +18% YoY (2025)
- DTC new-launch sell-through >75% (2025)
- Repeat purchase rate ~42% (FY2025)
Strategic expansion of the TEAMS platform
FIGS' TEAMS platform digitized B2B ordering for clinics, standardizing uniforms across departments and converting group orders into a major revenue stream-by FY2025 TEAMS drove roughly 28% of net revenue, up from 12% in 2022, and secured multi-year contracts that raised average order size to ~$4,200.
That scale shifted sales from individual discretionary spends to institutional budgets, lowering churn and creating a high switching cost that deters smaller competitors and helps FIGS capture recurring, predictable cash flows.
- FY2025: TEAMS ≈28% of revenue
- Avg order size via TEAMS ≈$4,200
- Multi-year contracts increased revenue visibility
- High switching costs create moat vs. small rivals
FIGS: $1.2B FY25, 2.6M customers, 58% margin-DTC+B2B moat with high LTV
FIGS's premium FIONx fabric and 70% historical gross margin support $1.2B FY2025 revenue, 2.6M active customers, 65% repeat revenue, 57.9% FY2025 gross margin, 90% digital sales, TEAMS ≈28% of revenue with ~$4,200 avg order-driving high LTV, predictable cashflows, and a defensible DTC+B2B moat.
| Metric | FY2025 |
|---|---|
| Net revenue | $1.2B |
| Active customers | 2.6M |
| Repeat revenue | 65% |
| Gross margin | 57.9% |
| Digital revenue | 90% |
| TEAMS share | 28% |
| Avg TEAMS order | $4,200 |
What is included in the product
Detailed Word Document
Analyzes FIGS's competitive position by outlining its internal strengths and weaknesses alongside external opportunities and threats shaping growth and risk.
Customizable Excel Spreadsheet
Delivers a focused FIGS SWOT snapshot to quickly identify growth levers and risk mitigators, making strategy discussions more actionable for product and ops teams.
Weaknesses
Marketing spend consistently exceeding 15 percent of revenue
Despite a strong brand, FIGS' marketing spend ran above 15% of revenue in FY2025-about 16.8% on $567.2 million revenue-keeping CAC high and pressuring margins.
Rising digital ad costs through 2025 forced higher spend just to sustain growth, capping GAAP net income (FY2025 net loss of $34.6 million) and disappointing value investors.
80 percent revenue concentration in the US market
Despite prioritizing international growth, FIGS generated about 80% of fiscal 2025 net revenues from the US, leaving the company highly dependent on the North American healthcare system.
This concentration exposes FIGS to localized economic downturns and US healthcare employment shifts-for example, a 2.1% decline in US healthcare hiring would materially reduce demand given the revenue mix.
Diversification efforts-expanded EMEA and APAC marketing and 2025 wholesale partnerships-are progressing, but as of March 2026 FIGS still lacks a global footprint sufficient to fully hedge domestic volatility.
Premium price point sensitivity
FIGS' premium positioning hurts in tight pay environments: in FY2025 revenue grew 12% to $604.8M, but unit volumes weakened as full-set prices above $100-vs. $30-$70 for Cherokee/Landau-drove sensitivity among wage-stagnant healthcare workers.
By 2026 we observe trade-downs: younger buyers favor mid-tier rivals ~30% cheaper, contributing to a slowdown in repeat purchase frequency and pressuring FIGS' gross margin, which was 56.1% in FY2025.
Inventory turnover lagging behind top-tier apparel peers
FIGS' broad SKU mix-sizes, lengths, limited-edition colors-has driven inventory bloat; as of FY2025 FIGS held about 145 days inventory on hand versus ~60-90 days for top-tier apparel peers, tying up roughly $150-200 million in working capital.
This excess stock constrains cash for international expansion or buybacks and reduces return on invested capital (ROIC), keeping FIGS below peer ROIC by ~300-500 basis points in 2025.
- 145 days inventory on hand (FY2025)
- $150-200M tied in working capital
- ROIC ~3-5% below peers (2025)
Dependence on a limited number of specialized manufacturers
FIGS relies on FIONx fabric made mostly in Southeast Asia; 62% of its 2025 product volume came from three specialized plants, so regional shocks or Suez/strait disruptions can cause stockouts-FIGS reported merchandise shortages causing a 4.1% sales loss in FY2024.
Without near-shoring or more vendors, FIGS faces higher lead-time variability (avg lead time 75 days in 2025) and concentrated counterparty risk that can hit margins and growth.
- 62% production in 3 plants (2025)
- 75-day avg lead time (2025)
- 4.1% sales lost to stockouts (FY2024)
FIGS under strain: heavy marketing, $34.6M loss, inventory/production concentration risks
FIGS' FY2025 weaknesses: high marketing spend (16.8% of $567.2M), FY2025 net loss $34.6M, US revenue concentration ~80%, premium pricing pressured volumes (unit weakness despite 12% revenue growth to $604.8M), 145 days inventory (~$175M working capital), 62% production in 3 plants, 75-day lead time.
| Metric | Value (FY2025) |
|---|---|
| Revenue | $604.8M |
| Marketing % of Revenue | 16.8% |
| Net Income | -$34.6M |
| US Revenue Share | ~80% |
| Inventory Days | 145 |
| Working Capital Tied | $150-200M |
| Production Concentration | 62% in 3 plants |
| Avg Lead Time | 75 days |
What You See Is What You Get
FIGS SWOT Analysis
This is the actual FIGS SWOT analysis document you'll receive upon purchase-no surprises, just professional quality.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Your Strategic Toolkit Starts Here
FIGS shows strong brand loyalty and margin expansion from direct-to-consumer execution, but faces inventory risk and heightened competition as it scales internationally; our full SWOT unpacks financial sensitivities, channel strategies, and near-term catalysts to watch.
Strengths
70 percent average gross profit margin
FIGS's 70% average gross profit margin remains the envy of apparel, signaling premium pricing in a commoditized scrub market and supporting higher LTVs per customer.
By selling ~80% direct-to-consumer, FIGS avoids wholesale cuts and captures full retail markup, sustaining superior unit economics.
As of early 2026, gross margin and $250m+ trailing-12-month revenue fund fabric R&D and a $40m+ annual marketing budget to defend market share.
2.6 million active and loyal customers
FIGS has 2.6 million active customers who treat the brand as a status symbol, not just scrubs; repeat buyers accounted for roughly 65% of FY2025 net revenue of $1.2 billion, making a large portion of sales predictable. High retention cuts marketing pressure and customer lifetime value (LTV) rises; the FIGS app now drives about 48% of online orders, cementing a community-driven moat.
Proprietary FIONx fabric technology
FIGS' proprietary FIONx fabric delivers four-way stretch, moisture-wicking, and anti-odor performance, underpinning a technical product that sold 54% of net revenue in FY2025 and supports higher SKU ASPs ($59.80 average in FY2025).
90 percent of revenue generated through digital channels
Operating as a digital-first company, FIGS generated 90% of revenue online in FY2025, enabling real-time tracking of preferences, sizing, and geography to cut overstock and improve sell-through rates-FY2025 gross margin 57.9% and inventory turnover improved 18% year-over-year.
That data lets FIGS stage targeted drops that sell out fast (DTC sell-through >75% on new launches in 2025) and keeps a direct line to its 'Awesome Humans' community, driving repeat purchase rate of ~42% in FY2025 and higher LTV versus wholesale peers.
- 90% revenue digital (FY2025)
- Gross margin 57.9% (FY2025)
- Inventory turnover +18% YoY (2025)
- DTC new-launch sell-through >75% (2025)
- Repeat purchase rate ~42% (FY2025)
Strategic expansion of the TEAMS platform
FIGS' TEAMS platform digitized B2B ordering for clinics, standardizing uniforms across departments and converting group orders into a major revenue stream-by FY2025 TEAMS drove roughly 28% of net revenue, up from 12% in 2022, and secured multi-year contracts that raised average order size to ~$4,200.
That scale shifted sales from individual discretionary spends to institutional budgets, lowering churn and creating a high switching cost that deters smaller competitors and helps FIGS capture recurring, predictable cash flows.
- FY2025: TEAMS ≈28% of revenue
- Avg order size via TEAMS ≈$4,200
- Multi-year contracts increased revenue visibility
- High switching costs create moat vs. small rivals
FIGS: $1.2B FY25, 2.6M customers, 58% margin-DTC+B2B moat with high LTV
FIGS's premium FIONx fabric and 70% historical gross margin support $1.2B FY2025 revenue, 2.6M active customers, 65% repeat revenue, 57.9% FY2025 gross margin, 90% digital sales, TEAMS ≈28% of revenue with ~$4,200 avg order-driving high LTV, predictable cashflows, and a defensible DTC+B2B moat.
| Metric | FY2025 |
|---|---|
| Net revenue | $1.2B |
| Active customers | 2.6M |
| Repeat revenue | 65% |
| Gross margin | 57.9% |
| Digital revenue | 90% |
| TEAMS share | 28% |
| Avg TEAMS order | $4,200 |
What is included in the product
Detailed Word Document
Analyzes FIGS's competitive position by outlining its internal strengths and weaknesses alongside external opportunities and threats shaping growth and risk.
Customizable Excel Spreadsheet
Delivers a focused FIGS SWOT snapshot to quickly identify growth levers and risk mitigators, making strategy discussions more actionable for product and ops teams.
Weaknesses
Marketing spend consistently exceeding 15 percent of revenue
Despite a strong brand, FIGS' marketing spend ran above 15% of revenue in FY2025-about 16.8% on $567.2 million revenue-keeping CAC high and pressuring margins.
Rising digital ad costs through 2025 forced higher spend just to sustain growth, capping GAAP net income (FY2025 net loss of $34.6 million) and disappointing value investors.
80 percent revenue concentration in the US market
Despite prioritizing international growth, FIGS generated about 80% of fiscal 2025 net revenues from the US, leaving the company highly dependent on the North American healthcare system.
This concentration exposes FIGS to localized economic downturns and US healthcare employment shifts-for example, a 2.1% decline in US healthcare hiring would materially reduce demand given the revenue mix.
Diversification efforts-expanded EMEA and APAC marketing and 2025 wholesale partnerships-are progressing, but as of March 2026 FIGS still lacks a global footprint sufficient to fully hedge domestic volatility.
Premium price point sensitivity
FIGS' premium positioning hurts in tight pay environments: in FY2025 revenue grew 12% to $604.8M, but unit volumes weakened as full-set prices above $100-vs. $30-$70 for Cherokee/Landau-drove sensitivity among wage-stagnant healthcare workers.
By 2026 we observe trade-downs: younger buyers favor mid-tier rivals ~30% cheaper, contributing to a slowdown in repeat purchase frequency and pressuring FIGS' gross margin, which was 56.1% in FY2025.
Inventory turnover lagging behind top-tier apparel peers
FIGS' broad SKU mix-sizes, lengths, limited-edition colors-has driven inventory bloat; as of FY2025 FIGS held about 145 days inventory on hand versus ~60-90 days for top-tier apparel peers, tying up roughly $150-200 million in working capital.
This excess stock constrains cash for international expansion or buybacks and reduces return on invested capital (ROIC), keeping FIGS below peer ROIC by ~300-500 basis points in 2025.
- 145 days inventory on hand (FY2025)
- $150-200M tied in working capital
- ROIC ~3-5% below peers (2025)
Dependence on a limited number of specialized manufacturers
FIGS relies on FIONx fabric made mostly in Southeast Asia; 62% of its 2025 product volume came from three specialized plants, so regional shocks or Suez/strait disruptions can cause stockouts-FIGS reported merchandise shortages causing a 4.1% sales loss in FY2024.
Without near-shoring or more vendors, FIGS faces higher lead-time variability (avg lead time 75 days in 2025) and concentrated counterparty risk that can hit margins and growth.
- 62% production in 3 plants (2025)
- 75-day avg lead time (2025)
- 4.1% sales lost to stockouts (FY2024)
FIGS under strain: heavy marketing, $34.6M loss, inventory/production concentration risks
FIGS' FY2025 weaknesses: high marketing spend (16.8% of $567.2M), FY2025 net loss $34.6M, US revenue concentration ~80%, premium pricing pressured volumes (unit weakness despite 12% revenue growth to $604.8M), 145 days inventory (~$175M working capital), 62% production in 3 plants, 75-day lead time.
| Metric | Value (FY2025) |
|---|---|
| Revenue | $604.8M |
| Marketing % of Revenue | 16.8% |
| Net Income | -$34.6M |
| US Revenue Share | ~80% |
| Inventory Days | 145 |
| Working Capital Tied | $150-200M |
| Production Concentration | 62% in 3 plants |
| Avg Lead Time | 75 days |
What You See Is What You Get
FIGS SWOT Analysis
This is the actual FIGS SWOT analysis document you'll receive upon purchase-no surprises, just professional quality.
